Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults

Context and Objectives Glucose metabolism becomes progressively impaired with older age. Fasting glucose and insulin resistance are risk factors for premature death and other adverse outcomes. We aimed to identifying plasma metabolites associated with altered glucose metabolism and insulin resistance in older community-dwelling adults. Participants and Methods A targeted metabolomics approach was used to identify plasma metabolites associated with impaired fasting plasma glucose, 2-hour plasma glucose on oral glucose tolerance testing, and homeostatic model assessment insulin resistance (HOMA-IR) in 472 participants who participated in the Baltimore Longitudinal Study of Aging, with a mean (SD) age of 70.7 (9.9) years. Results We measured 143 plasma metabolites. In ordinal logistic regression analyses, using a false discovery rate of 5% and adjusting for potential confounders, we found that alanine, glutamic acid, and proline were significantly associated with increased odds of abnormal fasting plasma glucose. Phosphatidylcholine (diacyl C34:4, alkyl-acyl C32:1, C32:2, C34:2, C34:3, and C36:3) was associated with decreased odds of abnormal fasting plasma glucose. Glutamic and acid phosphatidylcholine alkyl-acyl C34:2 were associated with increased and decreased odds of 2-hour plasma glucose, respectively. Glutamic acid was associated with increased odds of higher tertiles of HOMA-IR. Glycine; phosphatidylcholine (diacyl C32:0, alkyl-acyl C32:1, C32:2, C34:1, C34:2, C34:3, C36:2, C36:3, C40:5, C40:6, C42:3, C42:4, and C42:5); sphingomyelin C16:0, C24:1, and C26:1; and lysophosphatidylcholine C18:1 were associated with decreased odds of abnormal HOMA-IR. Conclusions Targeted metabolomics identified four plasma amino acids and 16 plasma lipid species, primarily containing polyunsaturated fatty acids, that were associated with abnormal glucose metabolism and insulin resistance in older adults.

[1]  J. Griffin,et al.  Metabolomics applied to diabetes-lessons from human population studies. , 2017, The international journal of biochemistry & cell biology.

[2]  M. Rutter,et al.  Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study. , 2017, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[3]  M. Adeva-Andany,et al.  Insulin resistance and glycine metabolism in humans , 2017, Amino Acids.

[4]  Sam R. Miller,et al.  Assessment of plasma acylcarnitines before and after weight loss in obese subjects. , 2016, Archives of biochemistry and biophysics.

[5]  K. Kaestner,et al.  Effects of ageing and senescence on pancreatic β‐cell function , 2016, Diabetes, obesity & metabolism.

[6]  M. Nishimura,et al.  Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance , 2016, Nutrition & Metabolism.

[7]  L. Geiss,et al.  Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. , 2015, JAMA.

[8]  W. Kraus,et al.  Impact of combined resistance and aerobic exercise training on branched-chain amino acid turnover, glycine metabolism and insulin sensitivity in overweight humans , 2015, Diabetologia.

[9]  P. Drábková,et al.  An Assay of Selected Serum Amino Acids in Patients with Type 2 Diabetes Mellitus. , 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[10]  G. Reaven,et al.  Relationship between insulin resistance and amino acids in women and men , 2015, Physiological reports.

[11]  A. El-Sohemy,et al.  Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults , 2015, PloS one.

[12]  L. Ferrucci,et al.  Hyperglycemia Predicts Persistently Lower Muscle Strength With Aging , 2014, Diabetes Care.

[13]  L. Price,et al.  Serum Glycine Is Associated with Regional Body Fat and Insulin Resistance in Functionally-Limited Older Adults , 2013, PloS one.

[14]  M. Adeva,et al.  Enzymes involved in l-lactate metabolism in humans. , 2013, Mitochondrion.

[15]  E. Gendaszewska-Darmach,et al.  Novel bioactive glycerol-based lysophospholipids: new data -- new insight into their function. , 2013, Biochimie.

[16]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[17]  F. Vaz,et al.  Acylcarnitines , 2012, Diabetes.

[18]  F. Vaz,et al.  Acylcarnitines , 2012, Diabetes.

[19]  L. Fried,et al.  Hyperglycemia and Incidence of Frailty and Lower Extremity Mobility Limitations in Older Women , 2012, Journal of the American Geriatrics Society.

[20]  F. Brunkhorst,et al.  Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients[S] , 2012, Journal of Lipid Research.

[21]  Jussi Paananen,et al.  Hyperglycemia and a Common Variant of GCKR Are Associated With the Levels of Eight Amino Acids in 9,369 Finnish Men , 2012, Diabetes.

[22]  Susan Cheng,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012, Circulation.

[23]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[24]  K. Bradbury,et al.  Serum Fatty Acid Reference Ranges: Percentiles from a New Zealand National Nutrition Survey , 2011, Nutrients.

[25]  F. Toledo,et al.  Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity , 2010, Obesity.

[26]  Desmond E. Williams,et al.  Full Accounting of Diabetes and Pre-Diabetes in the U.S. Population in 1988–1994 and 2005–2006 , 2009, Diabetes Care.

[27]  William E Grizzle,et al.  Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. , 2009, Journal of proteome research.

[28]  M. Köhler,et al.  Glutamate is a positive autocrine signal for glucagon release. , 2008, Cell metabolism.

[29]  G. Rechberger,et al.  Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M500054-JLR200 , 2005, Journal of Lipid Research.

[30]  John D. Storey,et al.  Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach , 2004 .

[31]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[32]  J. Meigs,et al.  The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. , 2003, Diabetes.

[33]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[34]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[35]  M. Stumvoll,et al.  Estimation of glucose-alanine-lactate-glutamine cycles in postabsorptive humans: role of skeletal muscle. , 1995, The American journal of physiology.

[36]  I. Rossman,et al.  Normal Human Aging: The Baltimore Longitudinal Study of Aging , 1986 .

[37]  David Arenberg,et al.  Normal Human Aging: The Baltimore Longitudinal Study on Aging , 1984 .

[38]  R. Sherwin,et al.  Amino acid and protein metabolism in diabetes mellitus. , 1977, Archives of internal medicine.

[39]  P. Felig.  The glucose-alanine cycle. , 1973, Metabolism: clinical and experimental.

[40]  P. Felig,et al.  Alanine: Key Role in Gluconeogenesis , 1970, Science.